Remove 2023 Remove Congenital Remove Congenital Heart Disease
article thumbnail

Right subaxillary small incision on low-age and low-weight infants with congenital heart disease

Frontiers in Cardiovascular Medicine

BackgroundAs a minimally invasive approach to treating congenital heart disease (CHD), the application of the right subaxillary small incision (RSSI) has been developing fast in its indication spectrum. The infants were divided into the RSSI group and the median sternotomy (MS) group.

article thumbnail

Hot Topics in Congenital and Pediatric Cardiology in the Year 2023

American College of Cardiology

This year saw exciting developments in the treatment of pediatric and congenital heart disease. Transcatheter pulmonary valve replacement (TPVR) continued to dominate the field of interventional cardiology.

article thumbnail

Mortality and Morbidity of Heart Failure Hospitalization in Adult Patients With Congenital Heart Disease

Journal of the American Heart Association

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundLittle is known about outcomes following heart failure (HF) hospitalization among adults with congenital heart disease (CHD) in the United States.

article thumbnail

Transcatheter Palliation With Pulmonary Artery Flow Restrictors in Neonates With Congenital Heart Disease: Feasibility, Outcomes, and Comparison With a Historical Hybrid Stage 1 Cohort

Circulation: Cardiovascular Interventions

Background:Neonates with complex congenital heart disease and pulmonary overcirculation have been historically treated surgically. However, subcohorts may benefit from less invasive procedures. kilograms [IQR, 2.1–3.3])

article thumbnail

Outcomes of cardiac resynchronization therapy in congenital heart disease: A meta?analysis and systematic review

Journal of Cardiovascular Electrophysiology

However, there is still a gap of evidence in congenital heart disease (CHD) patients regarding resynchronization therapy. We comprehensively searched the databases of MEDLINE, EMBASE, and Cochrane database from inception to June 2023.

article thumbnail

Transpulmonary Expression of Exosomal microRNAs in Idiopathic and Congenital Heart Disease–Related Pulmonary Arterial Hypertension

Journal of the American Heart Association

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundPulmonary artery hypertension (PAH) is a fatal disease characterized by a complex pathogenesis. Exosomes containing microRNAs (miRs) have emerged as a novel biomarker.

article thumbnail

Implementation of Rapid Genome Sequencing for Critically Ill Infants With Complex Congenital Heart Disease

Circulation: Genomic and Precision Medicine

Circulation: Genomic and Precision Medicine, Volume 16, Issue 5 , Page 415-420, October 1, 2023. BACKGROUND:Rapid genome sequencing (rGS) has been shown to improve care of critically ill infants.